Rodedawg enters into 11 Billion dollar topical pain relief market
Elixicure, Inc.
“Last year, Rodedawg acquired Elixicure’s assets of brands, manufacturing equipment, trade secrets, and online stores. According to Future Market Insights research, as the world continues to face chronic pain disorder burden, efficient and relieving topical pain relief becomes paramount for managing this condition. Given this, global demand for topical pain relief is anticipated to surge at a 5.6% CAGR through 2034. The market value is projected to increase from US$ 11 billion in 2024 to US$ 19 billion by 2034. The market was valued at US$ 10 billion in 2023 and is anticipated to exhibit a Y-o-Y growth of 5.2% in 2024. With this kind of growth and opportunity, the Company is now ready to rapidly expand Elixicure.”
Chris Swartz, CEO
"We are thrilled to welcome Jeff Byrne and Don Dedo to lead Elixicure, Inc. Their leadership and expertise will play a vital role in driving Elixicure's growth and success," said Chris Swartz, CEO of Rodedawg International Industries, Inc. "We are confident that with their guidance, Elixicure, Inc. will continue to thrive in the evolving cannabis market."
Chris Swartz, CEO
“Rodedawg International Industries, Inc. remains dedicated to growth through management services, acquisitions, and restructuring resources throughout the regulated California cannabis market. The company continues to uphold its commitment to delivering value to shareholders and driving growth opportunities within the industry. Our team will continue to provide updates on our key initiatives for share cancellation, key acquisitions, and upcoming audit initiative.”
Chris Swartz, CEO